Published ahead of print on March 6, 2003, doi:10.1165/rcmb.2002-0275OC
© 2003 American Thoracic Society DOI: 10.1165/rcmb.2002-0275OC Peroxynitrite Enhances Interleukin-10 Reduction in the Release of Neutrophil Chemotactic ActivityResearch Service, Southern Arizona Veterans Health Care System, and Arizona Respiratory Center, University of Arizona, Tucson, Arizona; Second Department of Surgery, and First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan Address correspondence to: Richard A. Robbins, M.D., Chief, Research Service Line, Southern Arizona Veterans Health Care System, 3601 S. 6th Avenue, Tucson, AZ 85723. E-mail: Richard.Robbins2{at}med.va.gov
Peroxynitrite, formed by nitric oxide and superoxide, has been shown to nitrate and reduce the function of proinflammatory proteins such as interleukin (IL)-8, monocyte chemoattractant protein-1, and eotaxin, but in contrast, to enhance the function of the anti-inflammatory cytokine IL-10 in reducing IL-1 release from blood monocytes. However, the effect of nitrated IL-10 on release of proinflammatory cytokines from lung epithelial cells is unknown. We hypothesized that peroxynitrite would enhance the capacity of human IL-10 to reduce inflammatory mediators released by epithelial cells. To test this hypothesis, recombinant human IL-10 was evaluated for its capacity to attenuate the release of neutrophil chemotactic activity and IL-8 from a human epithelial cell line in response to IL-1ß and tumor necrosis factor-
Abbreviations: enzyme-linked immunosorbent assay, ELISA high-power fields, HPF interleukin, IL neutrophil chemotactic activity, NCA regulated upon activation, normal T cell expressed and presumably secreted, RANTES reverse transcriptase-polymerase chain reaction, RT-PCR tumor necrosis factor-
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||